Scientific Writing: Assessing vaccine safety within Ontario’s Universal Influenza Immunization Program 2012–2013 to 2014–2015

摘要

BackgroundInfluenza vaccine is recommended to prevent influenza-related morbidity and mortality. Post-marketing surveillance of adverse events following influenza vaccine is essential to monitor vaccine safety, inform immunization program planning and evaluation, and build confidence in immunization.